Key result
Norovirus was associated with 65.0% of 206 gastroenteritis outbreaks in residential aged-care facilities, with 15 different capsid genotypes identified, most commonly GII.4.
Cross-Sectional (n=206)
Yes
Norovirus is a major cause of viral gastroenteritis in aged-care facilities, exhibiting significant genotype diversity that complicates potential vaccination strategies.
Supports norovirus surveillance in aged-care; leaves open multivalent vaccine feasibility given genotype diversity.
Noroviruses are a major cause of gastroenteritis. Vaccine strategies against norovirus are currently under consideration but depend on a detailed knowledge of the capsid genotypes. This study examined the incidence of norovirus outbreaks in residential aged-care facilities in Victoria, Australia over one year (2013) and documented the (capsid) norovirus genotypes associated with these outbreaks. It was found that 65·0% of 206 outbreaks tested were associated with norovirus infection, thereby showing norovirus to be the major cause of viral gastroenteritis in residential aged-care facilities. Fifteen capsid (open reading frame 2) genotypes were identified as follows: GI.2 (0·9%), GI.3 (1·8%), GI.4 (3·7%), GI.6 (0·9%), GI.7 (0·9%), GI.8 (0·9%), GII.1 (0·9%), GII.2 (0·9%), GII.3 (1·8%), GII.4 (2009-like) (0·9%), GII.4 (2012) (48·6%), GII.4 (2012-like) (16·5%), GII.4 (unknown) (9·2%), GII.5 (2·8%), GII.6 (0·9%), GII.7 (0·9%), GII.13 (6·4%) and an as yet unclassified GII genotype (0·9%). Although GII.4 was the most common norovirus capsid genotype detected, the great diversity of norovirus genotypes in the elderly indicates vaccination strategies for this demographic are not straightforward.
No takes yet. Share an insight, caveat, or question.
Bruggink et al. (2015) conducted a cross-sectional in Gastroenteritis outbreaks (n=206). Norovirus infection was evaluated on Proportion of outbreaks positive for norovirus. Norovirus was associated with 65.0% of 206 gastroenteritis outbreaks in residential aged-care facilities, with 15 different capsid genotypes identified, most commonly GII.4.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: